← FDA Drug Approvals (Drugs@FDA)
AMPHETAMINE SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SPECGX LLC · Approved 2021-01-22
Drug application
- FDA Application #
ANDA213583- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPHETAMINE SULFATE
- Generic name
- AMPHETAMINE SULFATE
- Active ingredients
- AMPHETAMINE SULFATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SPECGX LLC
- Manufacturer
- SpecGx LLC
- First approval
- 2021-01-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown